Druglike, 18 F-labeled PET Tracers Targeting Fibroblast Activation Protein
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.3c02402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Muhammet Tanc und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Endopeptidases, Fluorine Radioisotopes, Gelatinases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Fibroblast activation protein (FAP) is a very reliable biomarker for tissue remodeling. FAP has so far mainly been studied in oncology, but there is growing interest in the enzyme in other diseases like fibrosis. Recently, FAP-targeting diagnostics and therapeutics have emerged, of which the so-called FAPIs are among the most promising representatives. FAPIs typically have a relatively high molecular weight and contain very polar, multicharged chelator moieties. While this is not limiting the application of FAPIs in oncology, more druglike FAPIs could be required to optimally study diseases characterized by denser, less permeable tissue. In response, we designed the first druglike 18F-labeled FAPIs. We report target potencies, biodistribution, and pharmacokinetics and demonstrate FAP-dependent uptake in murine tumor xenografts. Finally, this paper puts forward compound 10 as a highly promising, druglike FAPI for 18F-PET imaging. This molecule is fit for additional studies in fibrosis and its preclinical profile warrants clinical investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.
- Laboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.
- Laboratory of Cell Biology and Histology, Department of Veterinary Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.
- Institut für Kernchemie, Johannes Gutenberg University of Mainz, Fritz-Strassman-Weg 2, D-55128 Mainz, Germany.
- Molecular Imaging and Radiology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.
ORCID-Profile: Nicolò Filippi, Koen Augustyns, Ingrid De Meester, Filipe Elvas, Pieter Van der Veken
Förderung
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Tanc, M., Filippi, N., Van Rymenant, Y., Grintsevich, S., Pintelon, I., Verschuuren, M., De Loose, J., Verhulst, E., Moon, E. S., Cianni, L., Stroobants, S., Augustyns, K., Roesch, F., De Meester, I., Elvas, F., & Van der Veken, P. (2024). Druglike, 18 F-labeled PET Tracers Targeting Fibroblast Activation Protein. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c02402
Vancouver
Tanc M, Filippi N, Van Rymenant Y, Grintsevich S, Pintelon I, Verschuuren M, et al. Druglike, 18 F-labeled PET Tracers Targeting Fibroblast Activation Protein. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.3c02402
BibTeX
@article{Tanc2024,
author = {Tanc, Muhammet and Filippi, Nicolò and Van Rymenant, Yentl and Grintsevich, Sergei and Pintelon, Isabel and Verschuuren, Marlies and De Loose, Joni and Verhulst, Emile and Moon, Euy Sung and Cianni, Lorenzo and Stroobants, Sigrid and Augustyns, Koen and Roesch, Frank and De Meester, Ingrid and Elvas, Filipe and Van der Veken, Pieter},
title = {Druglike, 18 F-labeled PET Tracers Targeting Fibroblast Activation Protein},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.3c02402}
}
EUVIMED